Novozymes reported 808.7M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Arq USD 35.92M 10K Dec/2025
Avient USD 2.41B 7.06B Mar/2026
Chemours USD 1.34B 11M Mar/2026
Coronado Global Resources USD 607.81M 42.77M Mar/2026
Corteva USD 4.43B 678.08M Jun/2026
Metallus USD 683M 399.4M Mar/2026
Newmont Corporation USD 2.82B 86M Mar/2026
Novozymes 808.7M 57M Dec/2025
SSR Mining USD 276.45M 15.3M Mar/2026